Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Neurology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location from dropdown

Headaches Clinical Trials

A listing of Headaches medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (227) clinical trials

Do you experience migraines? Rapid Medical Research is looking for volunteers to participate in a clinical research study for migraine headaches. Call Rapid Medical Research at 216-682-0320, Option 1 or visit www.rapidmedicalresearch.com. www.facebook.com/RapidMedicalResearchIncwww.twitter.com/RMRIncOhio

Phase

IA research study is evaluating an investigational medication for acute migraines. This research study may be an option if you: • Are at least 18 years of age • Have experienced migraines for at least 1 year with onset prior to age 50 • Are able to distinguish migraines from ...

Phase N/A

Does your child get migraines? The purpose of this research study is to measure how effective and how safe investigational zolmitriptan nasal spray is for acute migraine headaches in children ages 6 to 11 years old. This study requires up to 7 visits over 11 months.

Phase

People with Cluster Headaches are asked to participate in a registry being conducted by Montefiore Medical Center.

Phase N/A

  In this research study, doctors want to test the safety and effectiveness of the study drug for the acute treatment of Migraine.    Length of study: up to 54 weeks   Number of office visits: up to 18 visits   At no cost, qualified participants will receive:   Study-related ...

Phase N/A

Protocol:  IPX229-B16-01 This is a study to evaluate the efficacy and safety of zolmitriptan nasal spray (ZNS) in the acute treatment of migraine headache in subjects ages 6 to 11 years.

Phase

Protocol #: 20150308 Migraine prevention in Subjects with Chronic Migraine (CM) or Episodic Migraine (EM) comparing the treatment medication AMG 301 to placebo.

Phase

Rimegepant is being developed for the treatment of migraine, with a specific focus on acute treatment. Effectiveness against migraine was demonstrated in a Phase 2b double-blind, randomized, placebocontrolled, dose-ranging study where rimegepant at 75 mg showed efficacy on all four traditional endpoints: pain, nausea, photophobia and phonophobia.

Phase

To assess the single dose PK of galcanezumab administered via subcutaneous injection in a population of pediatric patients aged 6 to 17 years with migraine

Phase

This is a placebo controlled trial to test the efficacy and safety of AMG 301 in the prevention of episodic and chronic migraine. The treatment period is 12 weeks and the total study duration is 35 weeks.

Phase